The rates of ERα high-expression in normal ovary, serous cystadenoma, serous borderline tumor, and ovarian serous adenocarcinoma were 61.1, 45.7, 34.9 and 16.4%, respectively (Table S3). Here, ESR1 is linked to ovarian serous adenocarcinoma.